title: [Intensity modulated radiotherapy for intrathoracic cancers: a dangerous liaison? Our experience in the treatment of Hodgkin lymphoma mediastinal masses].
abstract: IMRT is a seducing treatment option in patients with Hodgkin lymphoma mediastinal masses due to the complex form of the tumour masses and their proximity to organs at risk such as the heart and the coronary arteries. This treatment delivery technique remains risky owing to respiratory movements and heart beats. The concomitant use of IMRT and respiratory gating is enticing, but a number of theoretical and practical hurdles remain to be resolved before it can be used in clinical daily practice.
authors: Département des radiations, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France. girinsky@igr.fr
authors: T
authors: T
authors: Girinsky
authors: M
authors: M
authors: Ghalibafian
authors: A
authors: A
authors: Paumier
mesh_terms: D000047:Academies and Institutes / Q000706:statistics & numerical data; D005602:France; D006689:Hodgkin Disease / Q000532:radiotherapy*; D006801:Humans; D015182:Lymphatic Irradiation / Q000379:methods*; D008482:Mediastinum / Q000528:radiation effects*; D009200:Myocardial Contraction; D058958:Organs at Risk; D011832:Radiation Injuries / Q000209:etiology / Q000517:prevention & control; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects; D012119:Respiration